{"id":"W4416003752","doi":"10.1038/s41698-025-01106-1","title":"Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations","year":2025,"lang":"en","type":"article","venue":"npj Precision Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Instituto de Salud Carlos III; European Regional Development Fund; Bayer Canada; European Commission","keywords":"Fibroblast growth factor receptor; Breast cancer; Clinical trial; Acquired resistance; Endocrine system; Biomarker; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007736685,0.0002096863,0.0007158286,0.0002305484,0.0001464802,0.00002220047,0.0001043346,0.0002564944,0.0001863162],"category_scores_gemma":[0.0003164983,0.0001623056,0.0000681398,0.0003582382,0.000316649,0.0001403023,0.00005962983,0.0005565705,0.000008777005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005099344,"about_ca_system_score_gemma":0.0008820231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001832065,"about_ca_topic_score_gemma":0.0006161681,"domain_scores_codex":[0.9977646,0.0003693148,0.0007396576,0.0005649568,0.0002307573,0.0003306589],"domain_scores_gemma":[0.9979524,0.001192058,0.0002107233,0.0002648784,0.0002380266,0.0001419214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.4094406,0.001173722,0.01708039,0.00004074723,0.0003123137,0.0002327558,0.001035632,0.00009640725,0.01295349,0.0006604044,0.004522107,0.5524514],"study_design_scores_gemma":[0.2160497,0.009533534,0.6396502,0.001174382,0.000362544,0.0002681703,0.001235852,0.0005449555,0.001757096,0.001958591,0.1268942,0.0005708206],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9692249,0.004151049,0.004062925,0.01296086,0.0007768555,0.001992369,0.0001326972,0.00007621737,0.006622154],"genre_scores_gemma":[0.9887955,0.0009361377,0.006476313,0.001698738,0.0005121234,0.0003157098,0.00004182162,0.00002875851,0.001194867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6225698,"threshold_uncertainty_score":0.6618631,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02880004581935899,"score_gpt":0.4263399839146925,"score_spread":0.3975399380953336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}